EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Infective endocarditis: Do we have an effective risk score model? A systematic review

Victoria Rizzo, Mohammad Yousuf Salmasi, Michael Sabetai, Christopher Primus, Jonathan Sandoe, Michael Lewis, Simon Woldman, Thanos Athanasiou

Frontiers in Cardiovascular Medicine · 20.02.2023 · 10

DOI: 10.3389/fcvm.2023.1093363 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.02.2023. Verfasst von Victoria Rizzo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Surgery, St. Thomas Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infective endocarditis (IE) is a rare, highly morbid condition with 17% in-hospital mortality. A total of 25–30% require surgery and there is ongoing debate with regard to markers predicting patient outcomes and guiding intervention. This systematic review aims to evaluate all IE risk scores currently available.

Methods

Standard methodology (PRISMA guideline) was used. Papers with risk score analysis for IE patients were included, with attention to studies reporting area under the receiver-operating characteristic curve (AUC/ROC). Qualitative analysis was carried out, including assessment of validation processes and comparison of these results to original derivation cohorts where available. Risk-of-bias analysis illustrated according to PROBAST guidelines.

Results

Of 75 articles initially identified, 32 papers were analyzed for a total of 20 proposed scores (range 66–13,000 patients), 14 of which were specific for IE. The number of variables per score ranged from 3 to 14 with only 50% including microbiological variables and 15% including biomarkers. The following scores had good performance (AUC > 0.8) in studies proposing the score (often the derivation cohort); however fared poorly when applied to a new cohort: PALSUSE, DeFeo, ANCLA, RISK-E, EndoSCORE, MELD-XI, COSTA, and SHARPEN. DeFeo score demonstrated the largest discrepancy with initial AUC of 0.88, compared to 0.58 when applied to different cohorts. The inflammatory response in IE has been well documented and CRP has been found to be an independent predictor for worse outcomes. There is ongoing investigation on alternate inflammatory biomarkers which may assist in IE management. Of the scores identified in this review, only three have included a biomarker as a predictor.

Conclusion

Despite the variety of available scores, their development has been limited by small sample size, retrospective collection of data and short-term outcomes, with lack of external validation, limiting their transportability. Future population studies and large comprehensive registries are required to address this unmet clinical need.

Schlagwörter

Stichwörter der Autor:innen

cardiac surgeryendocarditisoutcome assessmentrisk factorsrisk score

Autor:innen und Institutionen

  • Cardiothoracic Surgery, St. Thomas Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Department of Cardiothoracic Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Specialised Cardiology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Department of Microbiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Department of Cardiothoracic Surgery, Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom.

Zitieren

APA

Rizzo, V., Salmasi, M. Y., Sabetai, M., Primus, C., Sandoe, J., Lewis, M., Woldman, S., & Athanasiou, T. (2023). Infective endocarditis: Do we have an effective risk score model? A systematic review. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1093363

Vancouver

Rizzo V, Salmasi MY, Sabetai M, Primus C, Sandoe J, Lewis M, et al. Infective endocarditis: Do we have an effective risk score model? A systematic review. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1093363

BibTeX
@article{Rizzo2023,
  author = {Rizzo, Victoria and Salmasi, Mohammad Yousuf and Sabetai, Michael and Primus, Christopher and Sandoe, Jonathan and Lewis, Michael and Woldman, Simon and Athanasiou, Thanos},
  title = {Infective endocarditis: Do we have an effective risk score model? A systematic review},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1093363}
}
Kostenlos starten →